Healthcare & Medical

ASCO 2026: Designing the Next Generation of Oncology Trials

At ASCO 2026, Syneos Health highlights how adaptive oncology trial design can translate emerging science into faster, more meaningful outcomes for patients. The conference focuses on evolving oncology trial designs to support earlier insights, confident development decisions, and accelerated patient access. Key themes include MRD-driven strategies, advanced…

Visit the official site
2Speakers
1Sponsors
1Exhibitors
2On the bill · sessions
1Companies · in total
§I

Speakers

Programmed at ASCO, in alphabetical order.
Adele Stevenson Lampard
Ashley Moultrie
§II

Sponsors

The houses behind the program. Tiers as disclosed.
Syneos Health
§III

Agenda

Selected from 2 sessions on the bill.
  • March 2 | 4:30 PM

    PANEL | The Patient Voice

  • March 3 | 10:45 AM

    PANEL | Proven Paths for Building Community Trust

Intermission
Part the Second · For the Buyer

What does it mean when 1 companies show up — and 1 bet on three roles at once?

One companies. one are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
1All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
0Companies Speakingspeaker only

The Triple-Threat

Syneos Health

Speakers by seniority
  • Other roles2100%

Of 2 on the bill · classified by free-text title

Most-represented companies
  1. 01Syneos HealthSpEx
Sponsors by tier
unspecified1
100% of 1